The differences of asymmetric dimethylarginine removal by different dialysis treatments.

Item

http://www.wikidata.org/entity/Q42932776

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

The differences of asymmetric dimethylarginine removal by different dialysis treatments.

@en

The differences of asymmetric dimethylarginine removal by different dialysis treatments.

@nl

type

Item

label

The differences of asymmetric dimethylarginine removal by different dialysis treatments.

@en

The differences of asymmetric dimethylarginine removal by different dialysis treatments.

@nl

prefLabel

The differences of asymmetric dimethylarginine removal by different dialysis treatments.

@en

The differences of asymmetric dimethylarginine removal by different dialysis treatments.

@nl

P1476

The differences of asymmetric dimethylarginine removal by different dialysis treatments.

@en

P2093

Dong-Liang Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Sha Liu

http://www.w3.org/2001/XMLSchema#string

Wen-Hu Liu

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Dimethylarginines in chronic renal failure

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease.

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.

Impaired endothelial function in isolated human uremic resistance arteries.

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine.

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.

The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.

P304

935-940

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0886022X.2010.502281

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20722560

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis